TY - JOUR
T1 - microRNA-21 regulates astrocytic response following spinal cord injury
AU - Bhalala, Oneil G.
AU - Pan, Liuliu
AU - Sahni, Vibhu
AU - McGuire, Tammy L.
AU - Gruner, Katherine
AU - Tourtellotte, Warren G.
AU - Kessler, John A.
PY - 2012/12/12
Y1 - 2012/12/12
N2 - Astrogliosis following spinal cord injury (SCI) involves an early hypertrophic response that serves to repair damaged blood- brain barrier and a subsequent hyperplastic response that results in a dense scar that impedes axon regeneration. The mechanisms regulating these two phases of astrogliosis are beginning to be elucidated. In this study, we found that microRNA-21 (miR-21) increases in a timedependent manner following SCI in mouse. Astrocytes adjacent to the lesion area express high levels of miR-21 whereas astrocytes in uninjured spinal cord express low levels of miR-21. To study the role of miR-21 in astrocytes after SCI, transgenic mice were generated that conditionally overexpress either the primary miR-21 transcript in astrocytes or a miRNA sponge designed to inhibit miR-21 function. Overexpression of miR-21 in astrocytes attenuated the hypertrophic response to SCI. Conversely, expression of the miR-21 sponge augmented the hypertrophic phenotype, even in chronic stages of SCI recovery when astrocytes have normally become smaller in size with fine processes. Inhibition of miR-21 function in astrocytes also resulted in increased axon density within the lesion site. These findings demonstrate a novel role for miR-21 in regulating astrocytic hypertrophy and glial scar progression after SCI, and suggest miR-21 as a potential therapeutic target for manipulating gliosis and enhancing functional outcome.
AB - Astrogliosis following spinal cord injury (SCI) involves an early hypertrophic response that serves to repair damaged blood- brain barrier and a subsequent hyperplastic response that results in a dense scar that impedes axon regeneration. The mechanisms regulating these two phases of astrogliosis are beginning to be elucidated. In this study, we found that microRNA-21 (miR-21) increases in a timedependent manner following SCI in mouse. Astrocytes adjacent to the lesion area express high levels of miR-21 whereas astrocytes in uninjured spinal cord express low levels of miR-21. To study the role of miR-21 in astrocytes after SCI, transgenic mice were generated that conditionally overexpress either the primary miR-21 transcript in astrocytes or a miRNA sponge designed to inhibit miR-21 function. Overexpression of miR-21 in astrocytes attenuated the hypertrophic response to SCI. Conversely, expression of the miR-21 sponge augmented the hypertrophic phenotype, even in chronic stages of SCI recovery when astrocytes have normally become smaller in size with fine processes. Inhibition of miR-21 function in astrocytes also resulted in increased axon density within the lesion site. These findings demonstrate a novel role for miR-21 in regulating astrocytic hypertrophy and glial scar progression after SCI, and suggest miR-21 as a potential therapeutic target for manipulating gliosis and enhancing functional outcome.
UR - http://www.scopus.com/inward/record.url?scp=84870996530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870996530&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.3860-12.2012
DO - 10.1523/JNEUROSCI.3860-12.2012
M3 - Article
C2 - 23238710
AN - SCOPUS:84870996530
SN - 0270-6474
VL - 32
SP - 17935
EP - 17947
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 50
ER -